Name | Payless Pharmacy |
---|---|
Organization Name | Sand Drugs Inc |
Location | 1206 7th St Se, Decatur, Alabama 35601 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (256) 353-5011 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Complications after bariatric surgery appear similar between patients younger and older than age 60 and also between Medicare recipients and non-recipients, according to a study in the June issue of Archives of Surgery.
Electrophysiologists (EPs) rate the quality of life of patients with Paroxysmal atrial fibrillation (AF) significantly better than the patients themselves do, with the greatest level of disagreement about mental health.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.
› Verified 7 days ago
NPI Number | 1154354181 |
Organization Name | SAND DRUGS INC |
Doing Business As | PAY-LESS PHARMACY |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 1206 7th St Se, Decatur, AL 35601 |
Phone Number | 256-353-5011 |
News Archive
Complications after bariatric surgery appear similar between patients younger and older than age 60 and also between Medicare recipients and non-recipients, according to a study in the June issue of Archives of Surgery.
Electrophysiologists (EPs) rate the quality of life of patients with Paroxysmal atrial fibrillation (AF) significantly better than the patients themselves do, with the greatest level of disagreement about mental health.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.
› Verified 7 days ago
NPI Number | 1154461200 |
Organization Name | SAND DRUG INC |
Doing Business As | PAY-LESS DRIVE-IN PHARMACY |
Type | Community/Retail Pharmacy |
Address | 1206 7th St Se, Decatur, AL 35601 |
Phone Number | 256-353-5011 |
News Archive
Complications after bariatric surgery appear similar between patients younger and older than age 60 and also between Medicare recipients and non-recipients, according to a study in the June issue of Archives of Surgery.
Electrophysiologists (EPs) rate the quality of life of patients with Paroxysmal atrial fibrillation (AF) significantly better than the patients themselves do, with the greatest level of disagreement about mental health.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.
› Verified 7 days ago
NPI Number | 1316410863 |
Organization Name | SAND DRUG INC |
Type | Long Term Care Pharmacy |
Address | 1206 7th St Se, Decatur, AL 35601 |
Phone Number | 256-353-5011 |
News Archive
Complications after bariatric surgery appear similar between patients younger and older than age 60 and also between Medicare recipients and non-recipients, according to a study in the June issue of Archives of Surgery.
Electrophysiologists (EPs) rate the quality of life of patients with Paroxysmal atrial fibrillation (AF) significantly better than the patients themselves do, with the greatest level of disagreement about mental health.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.
› Verified 7 days ago
News Archive
Complications after bariatric surgery appear similar between patients younger and older than age 60 and also between Medicare recipients and non-recipients, according to a study in the June issue of Archives of Surgery.
Electrophysiologists (EPs) rate the quality of life of patients with Paroxysmal atrial fibrillation (AF) significantly better than the patients themselves do, with the greatest level of disagreement about mental health.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.
› Verified 7 days ago
Cvs Pharmacy #04844 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 812 Beltline Rd, Decatur, Alabama 35601 Phone: (256) 355-8465 | |
Cvs Pharmacy #17172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1235 Point Mallard Pkwy Se, Decatur, Alabama 35601 Phone: (256) 898-3034 | |
Alabama Orthotics & Prosthetics Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1021 6th Ave Se, Decatur, Alabama 35601 Phone: (256) 308-0200 | |
Pill Box Pharmacy Type: Community/Retail Pharmacy Location: 2422 Danville Rd Sw, Decatur, Alabama 35603 Phone: (256) 353-1121 | |
Bendalls Pharmacy Inc Type: Medicare Supplier Location: 1316a Stratford Rd Se, Decatur, Alabama 35601 Phone: (256) 353-2021 |